Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines. The Company’s focus areas for research are inflammation and immunology.
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.
